What Is Imunon, Inc. (IMNN) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Imunon, Inc.'s intrinsic value is estimated at a composite $2.93, showing conflicting signals at the current price of $1.93. While the average implied return is +51.7%, model disagreement is elevated with a gap of +498.5% between the most bullish and bearish estimates. The most optimistic model, Dynamic NAV, places fair value at $9.73 (+403.9%), while ML-RIV — the most conservative — estimates $0.10 (-94.6%). This +498.5% gap reflects genuine analytical uncertainty about Imunon, Inc.'s intrinsic worth.
What Do the Models Say About IMNN?
8 of 13 models are currently active for IMNN. Of these, 4 models suggest upside while 4 models suggest overvaluation. The Bayesian DCF estimates IMNN's intrinsic value at $1.01, implying -47.6% downside from the current price. See which stocks rank higher →
How Does IMNN Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, IMNN ranks #337 by Quality of Company score. CirclFi's QOC score of 4.0/10 evaluates 32 fundamental signals. A score of 4.0 signals below-average fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
Imunon, Inc.'s positioning within the Pharmaceutical Preparations segment means that biosimilar competition timeline plays an outsized role in fundamental analysis. The sector's unique characteristics — including therapeutic area leadership — shape both the opportunity set and risk profile.
Is IMNN a Value Trap?
CirclFi's Value Trap algorithm assigns IMNN a score of 47/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
8 of 13 models are active for Imunon, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, Imunon, Inc. earns a quality score of 4.0/10. This mixed rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency. Our Value Trap detector shows moderate caution signals worth monitoring.
The gap between the most bullish and bearish model spans +498.5% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every IMNN valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across IMNN's 8 active models, average confidence is 27%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad